Related Experiment Video
Updated: Aug 6, 2025
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
[Value of convalescent plasma in the therapy of COVID-19]
Sixten Körper1, Erhard Seifried2, Hubert Schrezenmeier3
1Institut für Klinische Tranfusionsmedizin und Immungenetik Ulm, Ulm, GERMANY.
Abstract:
Convalescent plasma was discussed as a therapeutic option early in the course of the COVID-19 pandemic. However, until the onset of the pandemic, only the results of mostly small single-arm studies in other infectious diseases were available, which did not prove efficacy. In the meantime, the results of more than 30 randomized trials of COVID-19 convalescent plasma (CCP) for treatment of COVID-19 are available 1. Despite the heterogeneity of the results, conclusions for an optimal use are possible.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:14Myocarditis III: Medical Management